CJC-1295 Ipamorelin 5MG/5MG

CJC-1295 Ipamorelin

CJC-1295 Ipamorelin is a research peptide combination consisting of CJC-1295, a synthetic growth hormone–releasing hormone (GHRH) analog, and Ipamorelin, a selective growth hormone secretagogue receptor (GHS-R) agonist. At Dobtry Peptides, this combination is supplied exclusively for laboratory research and in-vitro scientific investigation.

This formulation is widely utilized in experimental models examining growth hormone signaling dynamics, endocrine system regulation, and pulsatile secretion pathways. The complementary mechanisms of CJC-1295 and Ipamorelin provide researchers with a reliable framework for studying coordinated hormonal signaling without direct hormone administration.

Overview

CJC-1295 is designed to stimulate endogenous growth hormone release by interacting with GHRH receptors and extending signal duration. Ipamorelin selectively activates ghrelin receptors, promoting growth hormone secretion with minimal interaction with other endocrine pathways.

When studied together, CJC-1295 Ipamorelin is commonly used in research models to evaluate synergistic growth hormone signaling, receptor responsiveness, and hypothalamic–pituitary axis regulation under controlled laboratory conditions.

• Supports investigation of growth hormone release and signaling pathways
• Widely studied in endocrine and metabolic research models
• Combines GHRH analog and GHS-R agonist mechanisms
• Non-steroidal and non-anabolic research peptides
• Suitable for in-vitro and preclinical laboratory investigations

Specifications

• Peptide Components: CJC-1295 and Ipamorelin
• CJC-1295 Type: Growth hormone–releasing hormone (GHRH) analog
• Ipamorelin Type: Growth hormone secretagogue receptor agonist
• Research Type: Growth hormone and endocrine signaling model
• Alternate Names: CJC-1295 / Ipamorelin, GH Research Peptide Blend

Research Insights

Growth Hormone Signaling Pathways

Research involving CJC-1295 Ipamorelin focuses on endogenous growth hormone release mechanisms, receptor-mediated signaling, and pulsatile secretion dynamics.

Endocrine Regulation Models

This peptide combination is frequently used to study hypothalamic–pituitary axis function, hormonal feedback systems, and endocrine rhythm modulation in laboratory settings.

Selective Receptor Interaction

Ipamorelin is examined for its high selectivity toward ghrelin receptors, while CJC-1295 enhances GHRH receptor signaling, offering a targeted research model for endocrine studies.

Metabolic and Cellular Research Applications

CJC-1295 Ipamorelin is commonly incorporated into research exploring metabolic regulation, hormone-responsive cellular pathways, and signaling network interactions.

Usage & Handling

CJC-1295 Ipamorelin from Dobtry Peptides is supplied strictly for laboratory research and in-vitro use only. This product is not intended for human or animal consumption and is not approved for therapeutic, diagnostic, or clinical applications. All handling, storage, and experimental procedures must comply with institutional laboratory safety standards.

Notice: For research use only. Not for human or animal consumption.